/THIS MEDIA RELEASE IS NOT FOR DISTRIBUTION
TO UNITED STATES NEWSWIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED
STATES/
- Closing of Acquisition Scheduled for
June 27, 2022 -
TORONTO, June 7, 2022
/CNW/ - Neighbourly Pharmacy Inc. (TSX: NBLY) ("Neighbourly"
or the "Company"), is pleased to announce that it has
received a "no-action letter" from the Competition Bureau to
proceed with its previously announced acquisition of Rubicon
Pharmacies ("Rubicon").
"We are pleased that the Competition Bureau has concluded its
review of this combination of Canada's community pharmacy leaders," stated
Chris Gardner, the Company's Chief
Executive Officer. "The acquisition of Rubicon will ideally
position Neighbourly to continue to grow its presence across
Canada and expand its role as a
leader in community pharmacy. Rubicon's pharmacies are
similar to our own, acting as the centre of healthcare delivery for
smaller, underserved communities. However, our greatest similarity
is our shared values: both companies place an unmatched priority
upon patient-focused care."
As part of the agreement with the Competition Bureau, the
Company has agreed to sell two pharmacy locations in Saskatchewan. Net of the sale of these two
locations, the Rubicon acquisition will enable Neighbourly to
expand its network by 100 locations across key Western Canadian
provinces and increase its Pro Forma Adjusted EBITDA1 by
$41 million.
Neighbourly is also pleased to announce that it has received
waivers from the majority of third parties for the right of first
refusal ("ROFRs"). The final outstanding waiver is
expected imminently subject to the execution of customary franchise
agreements, which are currently being finalized. Neighbourly
expects to be able to acquire 100% of locations that were subject
to a ROFR.
Subject to the satisfaction of customary conditions for
transactions of this nature, Neighbourly expects the completion of
the acquisition to occur on June 27,
2022.
About Neighbourly Pharmacy
Inc.
Neighbourly is Canada's largest
and fastest growing network of community
pharmacies. United by their patient first focus and their
role as essential and trusted healthcare hubs within their
communities, Neighbourly's pharmacies strive to provide
accessible healthcare with a personal touch. Since 2015,
Neighbourly has expanded its diversified national
footprint to include 271 locations (on a pro forma
basis, after giving effect to the acquisition of Rubicon),
reinforcing the Company's reputation as the industry's acquirer of
choice.
Non-IFRS Measures
This news release makes reference to certain non-IFRS measures
that are used by the Company and Rubicon as indicators of financial
performance, such as, (a) with respect to Neighbourly: Pro Forma
Adjusted EBITDA, and (b) with respect to Rubicon: Rubicon Adjusted
EBITDA (as a measure forming part of Neighbourly's Pro Forma
Adjusted EBITDA). Refer to the Company's Management's Discussion
and Analysis dated February 15, 2022
for the 16-week and 40-week periods ended January 1, 2022, which is available under the
Company's profile on SEDAR at www.sedar.com, for an explanation of
the composition of Pro Forma Adjusted EBITDA, an explanation of how
such non-IFRS measure provides useful information to investors and
the additional purposes for which management uses Pro Forma
Adjusted EBITDA. Rubicon Adjusted EBITDA is defined as profit
(loss) for the twelve-month period ended September 30, 2021 before income tax expense
(recovery), finance (income) costs, net, depreciation and
amortization, and other expenses. These measures are not recognized
under International Financial Reporting Standards ("IFRS")
and do not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing further understanding of our results of operations from
management's perspective. Accordingly, these measures should not be
considered in isolation nor as a substitute for analysis of our
financial information reported under IFRS. These non-IFRS measures
are used to provide readers with supplemental measures of our
operating performance and thus highlight trends in our core
business that may not otherwise be apparent when relying solely on
IFRS measures. We also believe that market participants frequently
use non-IFRS measures in the evaluation of issuers. Our management
also uses non-IFRS measures in order to facilitate operating
performance comparisons from period to period, to prepare annual
operating budgets and forecasts and to determine components of
management compensation. See the financial table at the conclusion
of this news release for a reconciliation of these non-IFRS
measures to the most directly comparable IFRS measures.
Presentation of Financial
Information
The financial information of Neighbourly referred to in this
news release is reported in Canadian dollars and have been prepared
in accordance with IFRS. All financial information of Rubicon
referred to in this news release is reported in Canadian dollars
and has been derived from audited and unaudited historical
financial statements of Rubicon that were prepared in accordance
with Canadian accounting standards for private enterprises. The
recognition, measurement and disclosure requirements of Canadian
GAAP applicable to private enterprises differ from those of
Canadian GAAP applicable to publicly accountable enterprises, which
are IFRS.
Caution Regarding Forward-Looking
Statements
This news release contains "forward-looking information" and
"forward-looking statements" (collectively, "forward-looking
information") within the meaning of applicable securities laws.
Forward-looking information may relate to our future financial
results and may include information regarding our financial
position, business strategy, growth strategies, financial results,
taxes, dividend policy, plans and objectives. In some cases,
forward-looking information can be identified by the use of
forward-looking terminology such as "expects", "estimates",
"outlook", "forecasts", "projection", "prospects", "intends",
"anticipates", "believes", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "would", "might", "will", "will be taken", "occur" or "be
achieved". In addition, any statements that refer to expectations,
intentions, projections or other characterizations of future events
or circumstances contain forward-looking information. Statements
containing forward-looking information are not historical facts but
instead represent management's expectations, estimates and
projections regarding future events or circumstances.
Forward-looking information in this news release includes, among
other things, statements relating to the Acquisition and associated
anticipated benefits, the closing of the Acquisition and timing
thereof, the fact that closing of the Acquisition is conditional on
certain events occurring, and the receipt of all necessary
regulatory and other approvals.
Forward-looking information is necessarily based on a number of
opinions, estimates and assumptions that the Company considered
appropriate and reasonable as of the date such statements are made
in light of its experience and perception of historical trends,
current conditions and expected future developments. Such estimates
and assumptions include assumptions in respect of our ability to
build our market share; our ability to retain key personnel; our
ability to maintain and expand geographic scope; our ability to
execute on our expansion plans; our ability to continue investing
in infrastructure to support our growth; our ability to obtain and
maintain existing financing on acceptable terms; currency exchange
and interest rates; the impact of competition; the changes and
trends in our industry or the global economy; the changes in laws,
rules, regulations, and global standards, the satisfaction of all
conditions of closing and the successful completion of the
Acquisition within the anticipated timeframe, including receipt of
regulatory and other required approvals ; the estimated purchase
price of the Acquisition, including post-closing adjustments; the
receipt of consent of third parties to the change of control
triggered by the Acquisition under relevant agreements and store
leases; the successful and timely integration of Rubicon in the
timeframe anticipated; the realization of the anticipated benefits,
economies of scale, operating efficiencies, costs savings and
synergies of the Acquisition in the timeframe anticipated,
including impacts on growth and accretion in various financial
metrics; and the absence of significant undisclosed costs or
liabilities associated with the Acquisition, are material factors
made in preparing forward-looking information and management's
expectations.
Further, forward-looking information is subject to known and
unknown risks, uncertainties, assumptions and other factors that
may cause the actual results, level of activity, performance or
achievements to be materially different from those expressed or
implied by such forward-looking information, including but not
limited to risks and uncertainties related to the Acquisition,
including the failure to complete the Acquisition in all material
respects in accordance with the purchase agreement with respect to
the Acquisition; the failure to obtain, in a timely manner or at
all, regulatory and other required approvals , or to otherwise
satisfy the conditions to the completion of the Acquisition;
necessary borrowings under the Company's credit facilities may not
be available to fund a portion of the Acquisition; risks related to
increased indebtedness after completion of the Acquisition; the
failure to receive consents of third parties to the change of
control triggered by the Acquisition under relevant agreements and
store leases; the failure to realize the anticipated benefits,
economies of scale, operating efficiencies, costs savings and
synergies of the Acquisition in the timeframe anticipated, or at
all; the materiality of post-closing adjustments under the purchase
agreement; the Rubicon business may be adversely impacted during
the pendency of the Acquisition; the risk of potential unforeseen
difficulties in integrating the Rubicon business into the Company's
systems and operations; risks related to the dependence of the
Company on key employees and the loss of certain key Rubicon
personnel; significant undisclosed costs or liabilities associated
with the Acquisition may be discovered; risks of reliance on
information provided by Rubicon and the risk of inaccurate or
incomplete information, historical and/or stand-alone financial
information may not be representative of future performance,
uncertainty as to expected financial condition and economic
performance following the completion of the Acquisition, and
heightened exposure to regulatory environment in the Canadian
Prairies following the Acquisition; as well as other factors
discussed or referred to in the Company's Management's Discussion
and Analysis for the 16-week and 40-week periods ended January 1, 2022 and under the heading "Risk
Factors" in the final long form prospectus dated May 17, 2021 filed in connection with the initial
public offering of Neighbourly, both of which are available on
SEDAR at www.sedar.com under the Company's profile. If any of these
risks or uncertainties materialize, or if the opinions, estimates,
or assumptions underlying the forward-looking information prove
incorrect, actual results or future events might vary materially
from those anticipated in the forward-looking information.
Although we have attempted to identify important risk factors
that could cause actual results to differ materially from those
contained in forward-looking information, there may be other risk
factors not presently known to us or that we presently believe are
not material that could also cause actual results or future events
to differ materially from those expressed in such forward-looking
information. There can be no assurance that such information will
prove to be accurate, as actual results and future events could
differ materially from those anticipated in such information. No
forward-looking statement is a guarantee of future results.
Accordingly, you should not place undue reliance on forward-looking
information, which speaks only as of the date made. The
forward-looking information contained in this news release
represents the Company's expectations as of the date of this news
release (or as the date they are otherwise stated to be made) and
are subject to change after such date. However, the Company
disclaims any intention or obligation or undertaking to update or
revise any forward-looking information whether as a result of new
information, future events or otherwise, except as required under
applicable securities laws in Canada. All of the forward-looking information
contained in this news release is expressly qualified by the
foregoing cautionary statements.
Reconciliation from IFRS to Non-IFRS Measures
Reconciliation of Rubicon's Pro Forma Adjusted
EBITDA
|
|
9 months
ended
|
|
3 months
ended
|
in 000's
|
|
2021
|
|
2020
|
|
|
|
|
|
Loss and
comprehensive loss for the period
|
|
(13,785)
|
|
(3,945)
|
Income tax expense
(recovery)
|
|
(4,981)
|
|
(1,799)
|
Finance (income) costs,
net
|
|
29,353
|
|
9,324
|
Depreciation and
amortization
|
|
17,387
|
|
5,629
|
Other expenses (as
detailed in notes to financial statements)
|
|
109
|
|
122
|
Management fees and
expenses
|
|
465
|
|
183
|
Board of Director fees
and expenses
|
|
230
|
|
75
|
One time bad debt write
off and other
|
|
85
|
|
154
|
|
|
|
|
|
Adjusted
EBITDA
|
|
28,863
|
|
9,742
|
|
|
|
|
|
Revenue
|
|
224,816
|
|
77,990
|
Adjusted EBITDA
margin
|
|
12.8%
|
|
12.5%
|
|
|
|
|
|
Pro-Forma Adjusted
EBITDA
|
|
|
|
|
Adjusted EBITDA for the
9 months ended September 30, 2021
|
|
|
|
28,863
|
Adjusted EBITDA for the
3 months ended December 31, 2020
|
|
9,742
|
Management estimate of
identified synergies as if realized starting Sept 30,
2020
|
|
|
|
2,735
|
|
|
|
|
|
Pro-forma Adjusted
EBITDA for the 52 weeks ended September 2021
|
41,339
|
____________________________
|
1 Pro Forma
Adjusted EBITDA is a non-IFRS measure and does not have any
standard meaning under IFRS. See "Non-IFRS Measures" at the
conclusion of this news release.
|
SOURCE Neighbourly Pharmacy Inc.